Amgen sues Roche over new anaemia treatment

November 22, 2005
Sales and Marketing

Roche has released new phase II data for a highly promising new anaemia treatment – but Amgen are determined to …

New antibody could be COPD breakthrough, say companies

November 21, 2005
Research and Development Argenta, COPD, Domantis

 Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …

Asthma drug warning hits GlaxoSmithKline

November 21, 2005
Sales and Marketing

Sales of GlaxoSmithKline's number one product asthma drug Advair could be hit by new safety warnings imposed by the US …

Oxford and GSK to collaborate on cancer research in India

November 18, 2005
Research and Development

The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …

Which company is pharma’s rising star?

November 17, 2005
Sales and Marketing

Pharmaceutical executives are voting in their hundreds every week in a unique survey to find out which companies are the …

Patient demand brings Sativex to UK ahead of approval

November 17, 2005
Sales and Marketing GW Pharmaceuticals, Sativex

The unlicensed cannabis-based medicine Sativex will be available in the UK to treat neuropathic pain on a named patient basis …

Haringey spawns new NHS collaboration for Pfizer

November 17, 2005

Pfizer's high profile disease management project with Haringey Teaching PCT looks set to be declared a success – and has …

De Facto expands into med ed

November 17, 2005
Medical Communications

PR firm De Facto has launched a medical education arm and signed up its first two clients for the new …

Stricter new UK industry code of practice launched

November 16, 2005
Medical Communications, Sales and Marketing

The UK pharmaceutical industry is to adopt a new stricter code of conduct to help distance itself from allegations of …

Study results not IDEAL for Lipitor

November 16, 2005
Research and Development, Sales and Marketing

A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …

Complete prescribing power proposed for nurses and pharmacists

November 15, 2005

Some nurses and pharmacists could soon be able to prescribe almost any drug available on the NHS under sweeping changes …

Government should stay out of NHS medicines decisions, says ABPI

November 15, 2005

The ABPI has indicated its discomfort with government interference in NHS decision-making on medicines following the intervention of Patricia Hewitt …

Public’s expectations of NHS too high, say doctors

November 15, 2005

Most young doctors believe the public's expectations of the NHS are too high, according to a new survey.The BMA surveyed …

Animal rights and wrongs

November 14, 2005

With the recent cessation of guinea pig breeding at Darley Oaks Farm, after a protracted and sometimes violent campaign by …

Health secretary backs Herceptin use

November 10, 2005

North Stoke PCT will provide a mother of four with breast cancer drug Herceptin following mounting political and media pressure.Elaine …

Foundation Trust requirements relaxed

November 10, 2005

The government is opening up Foundation Trust status to more hospitals as it looks to accelerate health service reform.NHS Trusts …

NICE unveils fast track plans

November 10, 2005

NICE has unveiled plans to fast-track key new cancer drugs and other medicines through a new simplified appraisal process.The Institute …

Herbal medicines must prove safety

November 10, 2005
Sales and Marketing

The marketing of herbal medicines will now face stricter regulation across the European Union following the introduction of new legislation. …

GSK loses out on UK Seroxat patent

November 10, 2005
Sales and Marketing

GlaxoSmithKline has been defeated in a long-running battle over the UK patent on its antidepressant Seroxat.After four years of legal …

Agency to raise iron overload awareness for Novartis brand

November 10, 2005
Medical Communications

Ruder Finn has been awarded the UK contract to promote Novartis' new chronic iron overload product Exjade in a campaign …

The Gateway to Local Adoption Series

Latest content